Search results
Results from the WOW.Com Content Network
POLST (Physician Orders for Life-Sustaining Treatment) is an approach to improving end-of-life care in the United States, encouraging providers to speak with the severely ill and create specific medical orders to be honored by health care workers during a medical crisis. [1]
The MOLST Program is a New York State initiative that facilitates end-of-life medical decision-making. One goal of the MOLST Program is to ensure that decisions to withhold or withdraw life-sustaining treatment are made in accordance with the patient's wishes, or, if the patient's wishes are not reasonably known and cannot with reasonable diligence be ascertained, in accordance with the ...
Decisions about end-of-life care are often informed by medical, financial and ethical considerations. [ 3 ] [ 4 ] [ 1 ] In most developed countries, medical spending on people in the last twelve months of life makes up roughly 10% of total aggregate medical spending, while those in the last three years of life can cost up to 25%.
Generally, taking a heroic measure in attempts to save someone's life towards the end is more costly than pursuing non-heroic measures for treatment. [15] Overall, this raises questions and concerns regarding the cost of a person's life and if this is a factor that should be taken into consideration during end-of-life planning.
The National Hospice Organization (NHO) was established in 1978. By 1982, the US government began funding their work via the Medicare Hospice Benefit. In the United States, the Institute of medicine published a report, "Approaching Death: improving care at the end of life" (M.I. Field, and C.K. Kassel) in 1997.
An advance healthcare directive, also known as living will, personal directive, advance directive, medical directive or advance decision, is a legal document in which a person specifies what actions should be taken for their health if they are no longer able to make decisions for themselves because of illness or incapacity. In the U.S. it has a ...
Terminal illness or end-stage disease is a disease that cannot be cured or adequately treated and is expected to result in the death of the patient. This term is more commonly used for progressive diseases such as cancer, rather than fatal injury.
The Pathway was developed to aid members of a multi-disciplinary team in matters relating to continuing medical treatment, discontinuation of treatment and comfort measures during the last days and hours of a patient's life. The Liverpool Care Pathway was organised into sections ensuring that evaluation and care is continuous and consistent.